Idebenone

This product is a drug for improving brain metabolism and mental symptoms. It can activate the respiratory activity of brain mitochondria, improve brain energy metabolism of cerebral ischemia, improve the utilization rate of glucose in the brain, increase the production of ATP in the brain, inhibit the production of lipid peroxidation in brain mitochondria, and inhibit the membrane disorder caused by lipid peroxidation of brain mitochondrial membrane. This product has low toxicity and side effects. The LD50 of mice and rats is 10000mg/kg, rats are 20mg/(kgd) orally for half a year, and dogs are 100mg/(kgbull;d) orally for one year. No obvious toxicity is observed, and there is no teratogenic, carcinogenic, or mutagenic effect.

The main ingredient of this product is idebenone, and its chemical name is 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone.

Brain function damage caused by chronic cerebrovascular disease and brain trauma. It can improve subjective symptoms, language, anxiety, depression, memory loss, intellectual decline and other mental and behavioral disorders.

For adults, take 30 mg (1 tablet) orally, 3 times a day, after meals.

The incidence of adverse reactions is about 3%, mainly allergic reactions, rash, nausea, loss of appetite, diarrhea, excitement, insomnia, dizziness, etc. Occasionally, leukopenia and liver damage are seen.

Not yet clear

Store at room temperature.

Suzhou Lixin Pharmaceutical Co., Ltd.

• Founded in:

  1980-12-06

• Address:

  No. 21, Tangxi Road, Huguan Subdistrict, Suzhou High-tech Zone

• Tax NO.:

  91320505137996232U

• Registered Funds:

  20.78 million yuan

• Website:

  Log in to view

• Email:

  Log in to view